Hye Ryun Kim

8PUBLICATIONS

79CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicineMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jul 03, 2026

EpCAM<sup>+</sup> Extracellular Vesicle PD-L1 Dynamics as a Predictive Biomarker of Immune Checkpoint Blockade Response.

|Nov 25, 2025

Computed tomography-based unsupervised clustering identifies clusters associated with progression free survival in clear cell renal cell carcinoma.

Jae Hyon Park, Daeun Choi, Chung Lee

|Nov 14, 2025

HER2 Positivity as a Prognostic Biomarker and Therapeutic Target in Advanced Biliary Tract Cancer: A Multi-institutional Analysis.

Sunyoung S Lee, Dong Hyun Seo, Taek Chung

|Jan 21, 2025

Risk Factors for Progressive Disease After Immune Checkpoint Inhibitor Therapy in Head and Neck Squamous Cell Carcinoma.

Seo Yoon Jang, Yun-Gyoo Lee, Sang Hoon Chun

|Mar 08, 2024

A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma.

Chang Gon Kim, Min Hee Hong, Dahee Kim

|Dec 16, 2021

Primary Tumor Suppression and Systemic Immune Activation of Macrophages through the Sting Pathway in Metastatic Skin Tumor.

Chun-Bong Synn, Dong Kwon Kim, Jae Hwan Kim

Pageof 2

Frequent Collaborators

Min Hee Hong

Kyung Hwan Kim

Hye Ryun Kim

Gamin Kim

Eui-Cheol Shin

Chun-Bong Synn

Bhumsuk Keam

Jae Hwan Kim

Youngseon Byeon

Mi Ran Yun

Frequent Collaborators

Min Hee Hong

Kyung Hwan Kim

Hye Ryun Kim

Gamin Kim